Literature DB >> 20044205

Induction of neuronal apoptosis inhibitory protein expression in response to androgen deprivation in prostate cancer.

Helen H L Chiu1, Theresa M K Yong, Jun Wang, Yuwei Wang, Robert L Vessella, Takeshi Ueda, Yu-Zhuo Wang, Marianne D Sadar.   

Abstract

A mechanism for survival of prostate cancer cells in an androgen-deprived environment remains elusive. Here, we find that expression of neuronal apoptosis inhibitory protein (NAIP) was significantly increased in vivo and in vitro in response to androgen deprivation therapy (ADT). Increased expression of NAIP corresponded to increased DNA-binding activity of NF-kappaB that physically associated to previously uncharacterized kappaB-like sites in the NAIP locus. Importantly, expression of NAIP was significantly increased (p=0.04) in clinical samples of prostate cancer from patients receiving ADT. Expression of NAIP may be associated with enhanced survival of prostate cancer in response to castration. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20044205      PMCID: PMC3433396          DOI: 10.1016/j.canlet.2009.11.023

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  51 in total

1.  Characterization of a new in vivo hollow fiber model for the study of progression of prostate cancer to androgen independence.

Authors:  Marianne D Sadar; Violetta A Akopian; Eliana Beraldi
Journal:  Mol Cancer Ther       Date:  2002-06       Impact factor: 6.261

2.  A human IAP-family gene, apollon, expressed in human brain cancer cells.

Authors:  Z Chen; M Naito; S Hori; T Mashima; T Yamori; T Tsuruo
Journal:  Biochem Biophys Res Commun       Date:  1999-11-02       Impact factor: 3.575

3.  Molecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein family.

Authors:  B W Richter; S S Mir; L J Eiben; J Lewis; S B Reffey; A Frattini; L Tian; S Frank; R J Youle; D L Nelson; L D Notarangelo; P Vezzoni; H O Fearnhead; C S Duckett
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

4.  Functional human NAIP promoter transcription regulatory elements for the NAIP and PsiNAIP genes.

Authors:  Ming Xu; Takeya Okada; Harumi Sakai; Natsuki Miyamoto; Yoshiko Yanagisawa; Alex E MacKenzie; Shinji Hadano; Joh E Ikeda
Journal:  Biochim Biophys Acta       Date:  2002-02-20

5.  The neuronal apoptosis inhibitory protein is a direct inhibitor of caspases 3 and 7.

Authors:  Johannes K X Maier; Zahia Lahoua; Nathalie H Gendron; Raouf Fetni; Anne Johnston; Jamshid Davoodi; Dita Rasper; Sophie Roy; Ruth S Slack; Donald W Nicholson; Alex E MacKenzie
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

6.  Expression of the IAPs in multidrug resistant tumor cells.

Authors:  Monica Notarbartolo; Melchiorre Cervello; Paola Poma; Luisa Dusonchet; Maria Meli; Natale D'Alessandro
Journal:  Oncol Rep       Date:  2004-01       Impact factor: 3.906

Review 7.  Survivin, versatile modulation of cell division and apoptosis in cancer.

Authors:  Dario C Altieri
Journal:  Oncogene       Date:  2003-11-24       Impact factor: 9.867

Review 8.  The inhibitors of apoptosis: there is more to life than Bcl2.

Authors:  Peter Liston; Wai Gin Fong; Robert G Korneluk
Journal:  Oncogene       Date:  2003-11-24       Impact factor: 9.867

9.  Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen independence.

Authors:  Jason M D'Antonio; Changqing Ma; Federico A Monzon; Beth R Pflug
Journal:  Prostate       Date:  2008-05-15       Impact factor: 4.104

10.  Elevated expression of inhibitor of apoptosis proteins in prostate cancer.

Authors:  Maryla Krajewska; Stan Krajewski; Steven Banares; Xianshu Huang; Bruce Turner; Lukas Bubendorf; Olli-P Kallioniemi; Ahmed Shabaik; Antonella Vitiello; Donna Peehl; Guo-Jian Gao; John C Reed
Journal:  Clin Cancer Res       Date:  2003-10-15       Impact factor: 12.531

View more
  12 in total

1.  Improving clinical benefit for prostate cancer patients through the combination of androgen deprivation and immunotherapy.

Authors:  Anna R Kwilas; Sofia R Gameiro; Peter S Kim; Anthony S Malamas; James W Hodge
Journal:  Oncoimmunology       Date:  2015-03-02       Impact factor: 8.110

2.  NAIP expression increases in a rat model of liver mass restoration.

Authors:  Julio Plaza-Díaz; Ana I Álvarez-Mercado; Cándido Robles-Sánchez; Miguel Navarro-Oliveros; Virginia Morón-Calvente; Sofía Toribio-Castelló; María José Sáez-Lara; Alex MacKenzie; Luis Fontana; Francisco Abadía-Molina
Journal:  J Mol Histol       Date:  2020-11-25       Impact factor: 2.611

3.  Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.

Authors:  Jacqueline A Shaw; Karen Page; Kevin Blighe; Natasha Hava; David Guttery; Becky Ward; James Brown; Chetana Ruangpratheep; Justin Stebbing; Rachel Payne; Carlo Palmieri; Suzy Cleator; Rosemary A Walker; R Charles Coombes
Journal:  Genome Res       Date:  2011-10-11       Impact factor: 9.043

4.  Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathway.

Authors:  Andressa Ardiani; Sofia R Gameiro; Anna R Kwilas; Renee N Donahue; James W Hodge
Journal:  Oncotarget       Date:  2014-10-15

5.  Neuronal apoptosis inhibitory protein (NAIP) localizes to the cytokinetic machinery during cell division.

Authors:  Francisco Abadía-Molina; Virginia Morón-Calvente; Stephen D Baird; Fahad Shamim; Francisco Martín; Alex MacKenzie
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

Review 6.  Inflammasome as a Therapeutic Target for Cancer Prevention and Treatment.

Authors:  Huyen Trang Ha Thi; Suntaek Hong
Journal:  J Cancer Prev       Date:  2017-06-30

Review 7.  Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins.

Authors:  Darren Finlay; Peter Teriete; Mitchell Vamos; Nicholas D P Cosford; Kristiina Vuori
Journal:  F1000Res       Date:  2017-04-27

Review 8.  NOD-like receptors: major players (and targets) in the interface between innate immunity and cancer.

Authors:  Fernando J Velloso; Marina Trombetta-Lima; Valesca Anschau; Mari C Sogayar; Ricardo G Correa
Journal:  Biosci Rep       Date:  2019-04-09       Impact factor: 3.840

Review 9.  NLR-regulated pathways in cancer: opportunities and obstacles for therapeutic interventions.

Authors:  Nidhi Sharma; Sushmita Jha
Journal:  Cell Mol Life Sci       Date:  2015-12-26       Impact factor: 9.207

10.  Therapeutic potential of a novel prodrug of green tea extract in induction of apoptosis via ERK/JNK and Akt signaling pathway in human endometrial cancer.

Authors:  Gene Chi Wai Man; Jianzhang Wang; Yi Song; Jack Ho Wong; Yu Zhao; Tat San Lau; Kam Tong Leung; Tak Hang Chan; Huating Wang; Joseph Kwong; Tzi Bun Ng; Chi Chiu Wang
Journal:  BMC Cancer       Date:  2020-10-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.